this is prr not dendreon, page-16

Thanks 47 and Demonic, am reading all that comes out believe me. And I know the many other irons in the fire for PRR, i.e. commercialisation in Aus etc before FDA approval, Crypto-1 commercialiastion. PRR is a great stock and I am in for the long haul have had my poisiotns in heads and ops before 2009 and truly beleive that this stock will take me to places that I ahve only ever dreamed about. For me, the holy grail here is FDA approval -> commercialisation in the US. Was looking for more of an insight into the phaseIII trials given the orphan status. I recall reading that the treatment process for CVac is after an initial treatment, it is an injection every 7 weeks for 10 injections? It may have been on one of the company's own presentations. Will this push back FDA action?